Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$154,641,600
+$16,140,337 QoQ
Shares Held
288,000
+8.9% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
4.29%
of 13F equity value
Holder Rank
#17
of 413 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Sep 30, 2025CallValue
$59,625,800
CallShares
130,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. MDGL ranks #1 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in MDGL
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,641,600 | 288,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $138,501,263 | 264,583 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $154,730,649 | 265,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $59,625,800 | 130,000 | Call | Sole | 2025-11-17 | |
| 2025-09-30 | $55,030,944 | 119,982 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $37,527,360 | 124,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $51,448,800 | 170,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $99,369,000 | 300,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $45,008,526 | 135,883 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,857,000 | 100,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,592,961 | 49,915 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,024,000 | 150,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,862,720 | 168,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $64,786,400 | 280,000 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $11,569,000 | 50,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $15,772,320 | 108,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $23,366,400 | 160,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $73,920,000 | 320,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $31,416,000 | 136,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,282,500 | 125,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $66,863,760 | 276,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $60,372,000 | 208,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $80,327,640 | 1,236,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $78,738,000 | 1,100,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $95,961,360 | 978,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $95,247,760 | 1,124,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,662,440 | 1,036,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $57,666,720 | 592,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $40,939,500 | 350,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,129,720 | 316,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,006,940 | 278,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $28,086,000 | 248,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,420,160 | 216,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||